Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534854 | 0.81 | TSHR (0.39) | TDP1ROCK2 | |
| SCHEMBL2214760 | 0.80 | ROCK2 (0.36) | TDP1ROCK2 | |
| SCHEMBL2216461 | 0.80 | ROCK2 (0.32) | TDP1ROCK2 | |
| SCHEMBL11309790 | 0.77 | ROCK2 (0.45) | TDP1ROCK2 | |
| SCHEMBL11584678 | 0.76 | TDP1 (0.47) | TDP1ROCK2 | |
| SCHEMBL927428 | 0.75 | TDP1 (0.53) | TDP1ROCK2 | |
| SCHEMBL18947367 | 0.74 | TDP1 (0.45) | TDP1ROCK2 | |
| SCHEMBL24098178 | 0.72 | TDP1 (0.50) | TDP1ROCK2 | |
| SCHEMBL2214299 | 0.72 | TDP1 (0.50) | TDP1ROCK2 | |
| SCHEMBL2214777 | 0.72 | TDP1 (0.43) | TDP1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9637584-B2 | Method for producing polythiol compound, polymerizable composition for optical material, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2017-05-02 | — | — | US | disclosed |
| US-20160024242-A1 | METHOD FOR PRODUCING POLYTHIOL COMPOUND, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND USES THEREOF | MITSUI CHEMICALS., INC. (JP) | 2016-01-28 | — | — | US | disclosed |
| WO-2007072529-A2 | PROCESS FOR THE SYNTHESIS OF INTERMEDIATES FOR THE PREPARATION OF ASTAXANTHIN | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2007-06-28 | — | — | WO | disclosed |
| EP-0005749-B1 | DERIVATIVES OF CYCLOHEXENE, PROCESS FOR THEIR PEPARATION, AS WELL AS THEIR USES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-03-30 | — | — | EP | disclosed |
| US-4245109-A | Process for producing astaxanthin | HOFFMANN-LA ROCHE INC. (US) | 1981-01-13 | — | — | US | disclosed |
| EP-0005749-A2 | Derivatives of cyclohexene, process for their peparation, as well as their uses | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024242-A1 | METHOD FOR PRODUCING POLYTHIOL COMPOUND, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND USES THEREOF | TREH, CTH, PITHD1 | TDP1 2344/4885ROCK2 2479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.